metricas
covid
Buscar en
Clínica e Investigación en Arteriosclerosis
Toda la web
Inicio Clínica e Investigación en Arteriosclerosis Matrix metalloproteinase-9 pretreatment level predicts intracraneal hemorrhagic ...
Información de la revista
Vol. 16. Núm. 2.
Páginas 81-83 (enero 2004)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 16. Núm. 2.
Páginas 81-83 (enero 2004)
Acceso a texto completo
Matrix metalloproteinase-9 pretreatment level predicts intracraneal hemorrhagic complications after thrombolysis in human stroke
Los valores pretratamiento de la metaloproteinasa de matriz 9 son predictores de las complicaciones hemorrágicas intracraneales en el infarto cerebral humano
Visitas
754
L. Badimon, T. Padró
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
S.C. Patel, A. Mody.
Cerebral hemorrhagic complications of thrombolytic therapy.
Prog Cardiovasc Dis, 42 (1999), pp. 217-233
[2.]
NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke.
N Engl J Med, 333 (1995), pp. 1581-1587
[3.]
Ecass Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator in acute hemispheric stroke.
Jama, 274 (1995), pp. 1017-1025
[4.]
S. Mum-Bryce, G.A. Rosenberg.
Matrix metalloproteinases in cerebrovascular disease.
J Cerebral Blood Flow Metab, 18 (1998), pp. 1163-1172
[5.]
G.A. Rosenberg, J.E. Dencoff, P.G. McGuire, L.A. Liotta, W.G. Stetler-Stevenson.
Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain.
Lab Invest, 71 (1994), pp. 417-422
[6.]
A.M. Romanic, F.W. Raymond, A.J. Arleth, E.H. Ohlstein, F.C. Barone.
Matrix metalloproteinase expression increases after cerebral focal ischemia in rats.
Stroke, 29 (1998), pp. 1020-1030
[7.]
P.A. Lapchak, D.F. Chapman, J.A. Zivin.
Metalloproteinase inhibition reduces thrombolytic (tissue type plasminogen activator) induced hemorrhage after thrombolytic stroke.
Stroke, 31 (2000), pp. 3034-3040
[8.]
T. Sumii, E.H. Lo.
Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.
Stroke, 33 (2002), pp. 831-836
[9.]
J.H. Heo, J. Lucero, T. Abumiya, J.A. Koziol, B.R. Copeland, G.J. Del Zoppo.
Matrix metalloproteinases increase very early during experimental focal cerebral ischemia.
J Cereb Flow Metab, 19 (1999), pp. 624-633
[10.]
J. Montaner, J. Alvarez-Sabin, C.A. Molina, A. Anglés, S. Abilleira, J. Arenillas, et al.
Matrix metalloproteinase expresión is related to hemorrhagic transformation after cardioembolic stroke.
Stroke, 32 (2001), pp. 2762-2767
[11.]
M. Castellanos, R. Leira, J. Serena, J.M. Pumar, I. Lizasoain, J. Castillo, et al.
Plasma metalloproteinase-9 predicts hemorrhagic transformation in acute ischemic stroke.
Stroke, 34 (2003), pp. 40-46
[12.]
J. Montaner, C.A. Molina, J. Monasterio, S. Abilleira, J. Arenillas, M. Ribó, et al.
Matrix metalloproteinase-9 pretreatment level predicts intracraneal hemorrhagic complications after thrombolysis in human stroke.
Circulation, 107 (2003), pp. 598-603
Copyright © 2004. Sociedad Española de Arteriosclerosis y Elsevier España, S.L.
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos